R. Barker

The case for a national service for primary immune deficiency disorders in New Zealand.

K. Lindsay, R. Steele, R. Ameratunga, 2016, The New Zealand medical journal.

Clinical response to omalizumab in patients with hereditary alpha tryptasemia.

J. Lyons, K. Stone, J. Milner, 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Lesson of the month 1: Splinter haemorrhages as a pointer to gastrointestinal malignancy.

Rochelle Facer, S. Limaye, R. Barker, 2016, Clinical medicine.

Application of diagnostic and treatment criteria for common variable immunodeficiency disorder

R. Ameratunga, S. Woon, W. Koopmans, 2016, Expert review of clinical immunology.

Profound Reversible Hypogammaglobulinemia Caused by Celiac Disease in the Absence of Protein Losing Enteropathy

M. Yeong, R. Steele, R. Ameratunga, 2015, Journal of Clinical Immunology.

Bronchiectasis is associated with delayed diagnosis and adverse outcomes in the New Zealand Common Variable Immunodeficiency Disorders cohort study

S. Ameratunga, A. Cavadino, B. McGettigan, 2021, Clinical and experimental immunology.

Profound Reversible Hypogammaglobulinemia Caused by Celiac Disease in the Absence of Protein Losing Enteropathy

M. Yeong, R. Steele, R. Ameratunga, 2015, Journal of Clinical Immunology.